Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $481.16 million. The enterprise value is $1.01 billion.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 54.18 million shares outstanding. The number of shares has increased by 3.65% in one year.
| Current Share Class | 54.18M |
| Shares Outstanding | 54.18M |
| Shares Change (YoY) | +3.65% |
| Shares Change (QoQ) | +5.70% |
| Owned by Insiders (%) | 2.04% |
| Owned by Institutions (%) | 58.89% |
| Float | 53.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 3.88 |
| PS Ratio | 0.41 |
| Forward PS | 1.86 |
| PB Ratio | 0.94 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.48 |
| P/OCF Ratio | 2.82 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 7.29 |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 1.33.
| Current Ratio | 2.88 |
| Quick Ratio | 1.18 |
| Debt / Equity | 1.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | 4.90 |
| Interest Coverage | -1.46 |
Financial Efficiency
Return on equity (ROE) is -34.64% and return on invested capital (ROIC) is -5.15%.
| Return on Equity (ROE) | -34.64% |
| Return on Assets (ROA) | -4.22% |
| Return on Capital (ROIC) | -5.15% |
| Revenue Per Employee | $703,438 |
| Profits Per Employee | -$130,500 |
| Employee Count | 1,600 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.47 |
Taxes
In the past 12 months, EBS has paid $39.00 million in taxes.
| Income Tax | 39.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +333.17% in the last 52 weeks. The beta is 1.57, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +333.17% |
| 50-Day Moving Average | 8.72 |
| 200-Day Moving Average | 6.43 |
| Relative Strength Index (RSI) | 47.52 |
| Average Volume (20 Days) | 1,643,160 |
Short Selling Information
The latest short interest is 6.95 million, so 12.82% of the outstanding shares have been sold short.
| Short Interest | 6.95M |
| Short Previous Month | 8.23M |
| Short % of Shares Out | 12.82% |
| Short % of Float | 13.09% |
| Short Ratio (days to cover) | 5.21 |
Income Statement
In the last 12 months, EBS had revenue of $1.13 billion and -$208.80 million in losses. Loss per share was -$3.98.
| Revenue | 1.13B |
| Gross Profit | 290.30M |
| Operating Income | -113.80M |
| Pretax Income | -578.10M |
| Net Income | -208.80M |
| EBITDA | -4.80M |
| EBIT | -113.80M |
| Loss Per Share | -$3.98 |
Full Income StatementBalance Sheet
The company has $149.90 million in cash and $676.00 million in debt, giving a net cash position of -$526.10 million or -$9.71 per share.
| Cash & Cash Equivalents | 149.90M |
| Total Debt | 676.00M |
| Net Cash | -526.10M |
| Net Cash Per Share | -$9.71 |
| Equity (Book Value) | 508.40M |
| Book Value Per Share | 9.40 |
| Working Capital | 431.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $170.70 million and capital expenditures -$32.60 million, giving a free cash flow of $138.10 million.
| Operating Cash Flow | 170.70M |
| Capital Expenditures | -32.60M |
| Free Cash Flow | 138.10M |
| FCF Per Share | $2.55 |
Full Cash Flow StatementMargins
Gross margin is 25.79%, with operating and profit margins of -10.11% and -18.55%.
| Gross Margin | 25.79% |
| Operating Margin | -10.11% |
| Pretax Margin | -15.09% |
| Profit Margin | -18.55% |
| EBITDA Margin | -0.43% |
| EBIT Margin | -10.11% |
| FCF Margin | 3.41% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.65% |
| Shareholder Yield | -3.65% |
| Earnings Yield | -43.40% |
| FCF Yield | 28.70% |
Dividend DetailsAnalyst Forecast
The average price target for EBS is $14.00, which is 57.66% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 57.66% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 0.83 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 4 |